Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study-Reference-Cited by-同舟云学术

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study

Published:2012-02-21 Issue:6 Volume:42 Page:929-935
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Moldovan D.¹,Reshef A.²,Fabiani J.³,Kivity S.⁴,Toubi E.⁵,Shlesinger M.⁶,Triggiani M.⁷,Montinaro V.⁸,Cillari E.⁹,Realdi G.¹⁰,Cancian M.¹⁰,Visscher S.¹¹,Zanichelli A.¹²,Relan A.¹¹,Cicardi M.¹²

Affiliation:

1. Department of Allergology - Immunology; Mures County Hospital; University of Medicine and Pharmacy; Tîrgu-Mureş Romania

2. The Allergy and Clinical Immunology Unit; The Chaim Sheba Medical Center; Tel Hashomer Israel

3. Argentine Institute of Allergy and Immunology; Lezica Capital Federal Argentina

4. Allergy and Immunology Institute; Souraski MC; Tel-Aviv Israel

5. Immunology and Allergy Institute; Bnei Zion Hospital; Haifa Israel

6. Department of Immunology; The Barzilai M.C; Ashkelon Israel

7. Division of Allergy and Clinical Immunology; University of Naples Federico II; Naples Italy

8. Division of Nephrology; Azienda Ospedaliero-Universitaria “Consorziale Policlinico” Bari; Bari Italy

9. Department of Clinical Pathology; Azienda Ospedaliera “V.Cervello”; Palermo Italy

10. Department of Medical and Surgical Sciences; University of Padova; Italy

11. Pharming Technologies B.V; Leiden The Netherlands

12. Dipartimento di Scienze Cliniche “Luigi Sacco”; Università di Milano; Milan Italy

Funder

Pharming Technologies, B.V.

Shire Human Genetic Therapies Inc

CSL Behring

Dyax Corp

Shire

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2012.03984.x/fullpdf

Reference17 articles.

1. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress;Cugno;Trends Mol Med,2009

2. Local bradykinin generation in hereditary angioedema;Nussberger;J Allergy Clin Immunol,1999

3. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency;Bork;Arch Intern Med,2003

4. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate;Waytes;N Engl J Med,1996

5. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks;Craig;J Allergy Clin Immunol,2009

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hereditary Angioedema;Immunology and Allergy Clinics of North America;2023-08

2. Registry‐based analysis of Icatibant and C1‐inhibitor use in treatment of laryngeal attacks of hereditary angioedema;Clinical & Experimental Allergy;2022-06-13

3. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update;World Allergy Organization Journal;2022-03

4. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update;Allergy;2022-02-03

5. Hereditary Angioedema;Emergency Medicine Clinics of North America;2022-02